Effects of afterload reduction on vena contracta width in mitral regurgitation  by Kizilbash, Ali M. et al.
MITRAL REGURGITATION
Effects of Afterload Reduction on Vena Contracta Width in
Mitral Regurgitation
ALI M. KIZILBASH, MD, DUWAYNE L. WILLETT, MD, FACC,
M. ELIZABETH BRICKNER, MD, FACC, SHEILA K. HEINLE, MD, FACC,
PAUL A. GRAYBURN, MD, FACC
Dallas, Texas
Objectives. We used color Doppler flow mapping to determine
whether vena contracta width (VCW) is a load-independent
measure of the severity of mitral regurgitation.
Background. VCW has been proposed to be a relatively load-
independent measure of mitral regurgitation severity in flow
models using a fixed orifice. However, in patients with mitral
regurgitation, VCW may not be load independent because of a
dynamic regurgitant orifice.
Methods. VCW, effective regurgitant orifice area and regurgi-
tant volume were measured by quantitative Doppler mapping in
31 patients with chronic mitral regurgitation at baseline and
during nitroprusside infusion. Patients with rheumatic heart
disease, annular calcification or endocarditis were considered to
have a fixed regurgitant orifice, whereas patients with mitral valve
prolapse, dilated cardiomyopathy or ischemia were considered to
have a dynamic regurgitant orifice.
Results. Systolic blood pressure (148 6 27 to 115 6 25 mm Hg)
and end-systolic wall stress (121 6 50 to 89 6 36) decreased with
nitroprusside (p < 0.05). Although nitroprusside did not signifi-
cantly change mean values for VCW (0.5 6 0.2 to 0.5 6 0.2 cm),
regurgitant volume (69 6 47 to 69 6 56 ml) or effective regurgi-
tant orifice area (0.5 6 0.4 to 0.5 6 0.6 cm2), individual patients
exhibited marked directional variability. Specifically, VCW de-
creased in 16 patients (improved mitral regurgitation), remained
unchanged in 7 patients and increased in 8 patients (worsened
mitral regurgitation) with nitroprusside. Also, the VCW response
to nitroprusside was concordant with changes in effective regur-
gitant orifice area and regurgitant volume, and was not different
between dynamic and fixed orifice groups.
Conclusions. Contrary to the results from in vitro studies, VCW
is not load independent in patients with mitral regurgitation
caused by dynamic changes in the regurgitant orifice. The origin
of mitral regurgitation does not predict accurately whether the
regurgitant orifice is fixed or dynamic. Finally, short-term vaso-
dilation with nitroprusside may significantly worsen the severity
of mitral regurgitation in some patients.
(J Am Coll Cardiol 1998;32:427–31)
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Vena contracta width (VCW) as determined by Doppler color
mapping has emerged recently as a simple echocardiographic
marker of the severity of mitral regurgitation (MR) (1–5). The
vena contracta is the narrowest portion of the regurgitant jet
that occurs just downstream from the regurgitant orifice and
reflects the size of that orifice. On color flow mapping, VCW is
easily visualized and is not affected by flow rate, jet eccentricity
or instrument factors. On the basis of in vitro studies using a
fixed orifice, it has been proposed that VCW is relatively load
independent (6). However, patients with MR often have a
dynamic orifice, particularly in the setting of mitral valve
prolapse or dilated cardiomyopathy (7–10). Therefore, this
study was done to examine the effects of short-term changes in
loading conditions on VCW measurements in patients with
chronic MR.
Methods
Patients. The study was conducted at Parkland Memorial
Hospital and the Dallas Department of Veterans Affairs and
was approved by their Institutional Review Boards. All partic-
ipants gave written informed consent. The study population
consisted of 31 subjects with moderate or severe MR by
previous echocardiographic studies. The medical history and
echocardiogram were used to define the cause of MR, which
was used to classify patients as having either dynamic or fixed
regurgitant orifice. The dynamic orifice group consisted of
patients in whom MR was caused by mitral valve prolapse,
dilated cardiomyopathy or ischemia (7). The fixed orifice
group consisted of patients in whom MR was caused by mitral
annular calcification, endocarditis or rheumatic heart disease
(7). Patients were ineligible if they had mild MR or had
concomitant aortic regurgitation, aortic stenosis or mitral
stenosis. Patients were also excluded from the study if they
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were medically unstable, had severe renal insufficiency or had
a history of allergic reaction to nitroprusside.
Protocol. Heart rate (HR) and blood pressure (BP) were
monitored continuously by finger plethysmography (Finapres).
Arm cuff BP was also recorded every minute during the study
by using an automated sphygmomanometer (Dynamap). A
20-gauge venous catheter was placed in a forearm vein and 5%
dextrose water infusion was started at a slow rate. After 20
minutes of supine rest, baseline BP and HR values were
recorded. All patients underwent a complete two-dimensional
echocardiographic and Doppler study in the left lateral decu-
bitus position, from multiple imaging planes. Echocardio-
graphic studies were performed using a Sonos 2500 (Hewlett-
Packard, Andover, MA) with a 2.5-MHz transducer.
VCW was measured from the parasternal or apical long-
axis views by Doppler color flow mapping as described previ-
ously (4,5). The narrowest sector angle that allowed visualiza-
tion of the MR vena contracta was used to maximize color flow
imaging frame rate. In each patient, the transducer was angled
out of the standard echocardiographic planes to optimize
visualization of the area of proximal flow acceleration, the vena
contracta and the downstream expansion of the jet. For each
echocardiographic window, zoom mode was used to optimize
the visualization and measurement of VCW. In all patients
VCW was seen clearly, and its largest diameter during systole
was measured for at least three cardiac cycles and averaged.
Quantitative Doppler imaging was used to calculate effec-
tive regurgitant orifice area (EROA) and regurgitant volume
(RgV) using a modification of the method of Enriquez-Sarano
et al. (11,12). We have previously validated the accuracy of this
method in our laboratory by direct comparison with gated cine
magnetic resonance imaging, an independent reference stan-
dard (13). Briefly, the pulsed Doppler sample volume was
positioned to obtain modal velocity profiles for the aortic and
mitral annuli. The diameter of aortic annulus was measured in
the parasternal long-axis view and its area calculated as a
circle. Mitral annulus diameter was measured in the paraster-
nal long-axis and apical four-chamber views and its area
calculated as an ellipse (13). Continuous-wave was used to
measure the velocity-time integral of the MR jet. Aortic and
mitral flow volumes were calculated as the product of velocity-
time integral and cross-sectional area of the aortic and mitral
annuli, respectively. The RgV was determined as the mitral
flow volume minus the aortic flow volume. The EROA was
calculated as the RgV divided by the velocity-time integral of
the MR jet.
After baseline echocardiography, sodium nitroprusside was
infused at 0.25 mg/kg per minute and titrated to decrease
systolic BP at least 15% with a stable plateau. Echocardio-
graphic assessment of VCW, EROA and RgV was then
repeated. All studies were recorded on super-VHS videotape
for subsequent analysis.
Data analysis. All studies were interpreted in random
order by an experienced observer who had no knowledge of
patient identity and hemodynamic state. At least three mea-
surements were averaged for each hemodynamic state. Care
was taken to avoid postectopic beats. Because of previously
reported observer variability in measuring VCW, we consid-
ered a change of .0.1 cm to be clinically significant (4). A
paired t test was used to compare baseline values with those
obtained after nitroprusside infusion. The magnitude of
change in MR with nitroprusside in the dynamic and fixed
orifice groups was compared using a two-way repeated-
measures analysis of variance.
Results
Patient characteristics. The patients were 29 to 77 years
old (mean 56 6 14 years). There were 10 women and 21 men.
The dynamic orifice group consisted of 18 patients, in whom
MR was associated with mitral valve prolapse in 9, dilated
cardiomyopathy in 7 and ischemic MR in 2. The fixed orifice
group consisted of 13 patients, in whom MR was associated
with mitral annular calcification in 5, infective endocarditis in
5 and rheumatic heart disease in 3. By qualitative grading, 16
patients had moderate MR and 15 had severe MR at baseline;
20 patients had an eccentric jet and 11 had a central jet.
Hemodynamic changes with nitroprusside. Hemodynamic
values before and after nitroprusside infusion are shown in
Table 1. Mean baseline systolic BP dropped significantly from
148 6 27 to 115 6 25 mm Hg with nitroprusside (p , 0.0001).
Moreover, each patient had a decrease in systolic BP of at least
15%. Similarly, diastolic BP (83 6 16 to 65 6 16 mm Hg) and
mean arterial BP (105 6 17 to 81 6 17 mm Hg) decreased
significantly (p , 0.0001). Although both left ventricular
Abbreviations and Acronyms
BP 5 blood pressure
EROA 5 effective regurgitant orifice area
HR 5 heart rate
MR 5 mitral regurgitation
RgV 5 regurgitant volume
ROA 5 regurgitant orifice area
VCW 5 vena contracta width
Table 1. Changes in Hemodynamic Variables With
Nitroprusside Therapy
Variable Baseline Nitroprusside p Value
Systolic BP (mm Hg) 148 6 27 115 6 25 , 0.0001
Diastolic BP (mm Hg) 83 6 16 65 6 16 , 0.0001
Mean arterial BP (mm Hg) 105 6 17 81 6 17 , 0.0001
HR (beats/min) 79 6 17 84 6 18 NS
LV end-diastolic dimension (cm) 5.5 6 0.8 5.3 6 0.8 , 0.0001
LV end-systolic dimension (cm) 4.3 6 0.9 4.2 6 0.9 , 0.04
Posterior wall thickness (cm) 1.4 6 0.4 1.4 6 0.4 NS
End-systolic wall stress (dynes/cm2) 121 6 50 89 6 36 , 0.0001
Data are expressed as mean 6 1 SD. LV 5 left ventricle; NS 5 not
significant.
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end-diastolic dimension (preload) and end-systolic wall stress
(afterload) decreased significantly with nitroprusside (p ,
0.0001), the magnitude of change in afterload was more
pronounced. The magnitude of change in HR, BP, left ven-
tricular end-diastolic dimension and end-systolic wall stress
was not significantly different between the dynamic and fixed
orifice groups. All patients tolerated the medication well and
there were no untoward events.
Change in MR severity with nitroprusside. Measurements
of MR severity before and after nitroprusside infusion are
shown in Table 2. Although nitroprusside did not significantly
change the mean values for VCW or quantitative Doppler
measures of MR severity, individual patients demonstrated
marked directional variability. Specifically, 8 patients (26%)
had worsened MR by all measurements, 16 (52%) had im-
proved MR severity, and 7 (22%) were unchanged. Also, the
directional change in VCW with nitroprusside in individual
patients was concordant with the respective changes in EROA
and RgV in 27 (87%) of 31 patients. For a 0.1-cm change
in VCW, change in RgV averaged 16.4 ml. Individual values
for VCW at baseline and after nitroprusside are shown in
Figure 1.
MR response to nitroprusside in dynamic versus fixed
orifice groups. Baseline values for mean VCW, EROA and
RgV were similar for patients in the dynamic and fixed orifice
groups. Likewise, the change in these values after nitroprusside
was administered did not differ significantly between groups by
two-way analysis of variance (F 5 0.67, p 5 0.42). Individual
patients from both groups demonstrated marked directional
change in MR severity with nitroprusside (Fig. 2).
Discussion
This study was designed to test the hypothesis that VCW is
independent of loading conditions in patients with chronic
MR. The group mean data support this hypothesis because the
change in VCW from baseline to nitroprusside administration
was not statistically significant. However, despite the absence
of a group mean change, individual patients had divergent
responses, with a decrease in VCW in 52%, an increase in 26%
and no significant change in 22% of patients. These data were
concordant with the quantitative Doppler measurements of
EROA and RgV, suggesting that most patients had a true
change in the regurgitant orifice during nitroprusside infusion.
Although in vitro studies using rigid orifices show that VCW is
flow independent (6), our data confirm that the regurgitant
orifice in MR is dynamic and may change in either direction
with short-term change in loading conditions (7–10). All
patients in this study had a decrease in BP of at least 15%, with
a stable plateau to allow measurements of VCW, RgV and
ROA. There was no difference in the magnitude of the change
in BP (F 5 1.26, p 5 0.30) or HR (F 5 0.80, p 5 0.46) in the
patients with worsened MR compared with those with im-
proved or unchanged MR. Figure 3 shows a Doppler map of a
patient from this study in whom MR severity worsened during
nitroprusside infusion.
Causes of MR. These data also demonstrate that, contrary
to conventional wisdom, etiologic determination of MR does
not always accurately predict whether the regurgitant orifice is
dynamic or fixed in individual patients. For example, of nine
Figure 1. Individual values for VCW at baseline and after sodium
nitroprusside. Despite the absence of a significant change in mean
values, individual patients had marked directional variability.
Figure 2. Change in VCW from baseline to after nitroprusside for the
31 patients in the study. Closed circles represent patients thought to
have a dynamic orifice according to cause of MR; open circles
represent patients thought to have a fixed orifice according to cause of
MR.
Table 2. Changes in Echocardiographic Markers of Severity of
Mitral Regurgitation With Nitroprusside
Variable Baseline Nitroprusside
Vena contracta width (cm) 0.5 6 0.2 0.5 6 0.2
Regurgitant orifice area (cm2) 0.52 6 0.4 0.57 6 0.57
Regurgitant volume (ml) 69 6 47 69 6 56
Regurgitant fraction (%) 59 6 18 55 6 18
Data are expressed as mean 6 1 SD. No comparisons between baseline and
nitroprusside were statistically significant.
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patients with mitral valve prolapse in our study, MR worsened
in four, improved in three and remained unchanged in two
after nitroprusside. Similarly, divergent responses were ob-
served in patients with MR attributable to ischemia, rheumatic
heart disease, mitral annular calcification and endocarditis.
Accordingly, in some patients who were classified as having a
fixed orifice on the basis of an associated condition, there were
marked changes in EROA with nitroprusside, whereas EROA
was unchanged in some patients who presumably had a
dynamic orifice.
Clinical implications. This study also has important clini-
cal implications regarding the use of vasodilator therapy for
MR. Long-term use of vasodilator therapy for MR is contro-
versial. Starling (14) has proposed that long-term vasodilator
therapy may have adverse effects on ventricular-arterial cou-
pling in chronic MR. There are no large-scale randomized
trials that evaluated the efficacy of vasodilator therapy, and
small studies yielded conflicting results. Recently, Levine and
Gaasch (10) reviewed these studies, the largest of which
comprised 16 patients, and proposed that the conflicting
results could be attributed to inclusion of different causes of
MR. Studies that included MR primarily caused by rheumatic
heart disease or mitral annular calcification might fail to show
benefit of vasodilator therapy because these patients are
thought to have a fixed orifice. Conversely, studies including
patients with MR caused by dilated cardiomyopathy might
show a benefit because these patients are thought to have a
dynamic orifice that becomes smaller with reduction in after-
load. However, our data indicate that the cause of MR alone
does not predict accurately whether the regurgitant orifice is
fixed or dynamic. Moreover, worsening of MR with short-term
vasodilator therapy occurred in 26% of our patients, suggesting
that some patients with chronic MR might be harmed by
vasodilator therapy. It remains to be determined whether the
response of MR to nitroprusside can identify patients who are
likely to benefit from long-term vasodilator therapy.
Limitations. Although this is the largest reported study on
the effects of short-term vasodilation on MR, the number of
patients was too small to allow subgroup analysis of which
specific etiologic categories of MR consistently benefit from
short-term vasodilator therapy. However, it is worth noting
that none of the patients with dilated cardiomyopathy had
worsened MR after nitroprusside. It is possible that the
short-term response of MR to nitroprusside does not predict
the long-term response to vasodilators or angiotensin-
converting enzyme inhibitors, the latter of which may have
beneficial neurohormonal or myocardial effects that are unre-
lated to short-term hemodynamic effects. Such beneficial ef-
fects might overcome mild worsening of MR from hemody-
namic changes. In addition, the hemodynamic changes in this
study were moderate, as manifested by a roughly 25% reduc-
tion in BP and wall stress. Larger changes in afterload may
have produced different results. We did not attempt to reduce
BP further for safety reasons.
The present study was limited to patients thought to have
moderate to severe MR by subjective interpretation of a
previous echocardiogram. The mean values for RgV and
EROA shown in Table 2 are consistent with angiographically
severe MR (15). However, it is evident that some individuals
had mild MR by quantitative Doppler imaging and by VCW,
which further emphasizes the limitations of subjective grading
of MR by color flow mapping. Patients with mild MR would
not be considered candidates for vasodilator therapy unless
they also had underlying cardiomyopathy.
Conclusion. VCW is not load independent in MR because
short-term changes in loading conditions produce dynamic
changes in the regurgitant orifice. Cause of MR does not
always predict accurately whether the regurgitant orifice is
fixed or dynamic. Short-term vasodilator therapy with sodium
nitroprusside worsens MR in some patients; whether this
response predicts the response to long-term vasodilator ther-
apy requires further study.
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